Impact Factor
4.25
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
6.13
2,270 total citations
h5-index
58
h5 depth signal
Cited share
79.4%
313 of 394
Total citations
2,270
Citation footprint
Metric signal
8.30
External metric anchor
Self-citation
5.8%
131 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
830
China
239
South Korea
207
Italy
180
Netherlands
144
Citing Fields of Research
Endocrinology & Metabolism
1,952
Oncology
221
Cancer & Development
82
Immunology
68
Endocrine Therapy
65
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
7,146
Articles tracked across the journal lifetime
Indexed publication set
394
313 cited publications
Last 12 months
151
13.7 publications/month
Open access share
11.9%
18 OA publications in the last year
Leading citing country
United States
830 citing publications
Leading citing field
Endocrinology & Metabolism
1,952 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1990-
v1n1, 1990-
Active Coverage
Research Focus & Classification
Indexed Subjects
Endocrinology & Metabolism
Issuing & Sponsoring Bodies
Contributor
American Thyroid Association
Broad Categories
Endocrinology
Endocrinology & Metabolism
MeSH Descriptors
Thyroid Diseases
Thyroid Hormones
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/10507256261497620
Open DOI
Precision Thyroid Oncology Using Genetic-Based Therapies: A Narrative Review
Background: Most thyroid malignancies harbor a limited set of well-characterized mutations driving tumor initiation and determining phenotype. This relatively direct genotype–phenotype association, bringing insights into molecular mechan...
02
DOI 10.1177/10507256261499156
Open DOI
Letter: The Iatrogenic Delay Paradox: A Call for Contextual Adaptation of the 2026 ATA Guidelines
03
DOI 10.1177/10507256261494905
Open DOI
Radiofrequency Ablation of Calcified Papillary Thyroid Microcarcinoma: Long-Term Imaging Evolution and Clinical Outcomes
Background: Radiofrequency ablation (RFA) is a minimally invasive treatment for low-risk papillary thyroid microcarcinoma (PTMC). Although intratumoral calcification is a common feature of papillary thyroid carcinoma (PTC), its impact on...
04
DOI 10.1177/10507256261493011
Open DOI
Locoregional Control and Toxicity of Neck Radiation with Field Reduction in Advanced Differentiated Thyroid Carcinoma: A Retrospective Cohort Study
Background: External beam radiotherapy (RT) is indicated for high-risk, gross residual, unresected, or recurrent differentiated thyroid cancer (DTC) when further surgery is not recommended. Although RT improves time to locoregional contr...
05
DOI 10.1177/10507256261495805
Open DOI
Changes in Multisystem Morbidity in Thyroid Cancer after the 2015 ATA Guideline: A Nationwide Population-Based Retrospective Cohort Study
Background: As survivorship has become increasingly important in differentiated thyroid cancer (DTC), the 2015 American Thyroid Association (ATA) guideline introduced a more risk-adapted and less intensive approach to management. However...
06
DOI 10.1177/10507256261494909
Open DOI
Longitudinal Ultrasonographic Analysis of Involutional Changes after Radiofrequency Ablation of Papillary Thyroid Microcarcinoma
Background: Radiofrequency ablation (RFA) has emerged as an effective nonsurgical treatment for low-risk papillary thyroid microcarcinoma (PTMC), with widely variable rates of complete disappearance reported. The purpose of our study was...
07
DOI 10.1177/10507256261494916
Open DOI
Comparative Performance of the 2015 and 2025 American Thyroid Association Initial Recurrence Risk Stratification Systems in Differentiated Thyroid Cancer
Background: The 2025 American Thyroid Association (ATA) guidelines introduced significant modifications to the initial risk stratification system for differentiated thyroid cancer (DTC). However, the real-world prognostic performance and...
08
DOI 10.1177/10507256261493762
Open DOI
RET Variant Reclassification across Demographic Sub-Groups in a Large-Scale Clinical Population
Background: The expanded use of germline testing panels that include the RET proto-oncogene has identified many variants of uncertain significance (VUSs). It remains poorly understood how many RET VUSs are returned in clinical practice, ...
09
DOI 10.1177/10507256261493805
Open DOI
Zingiberen Newsaponin Enhances Antitumor Immunity in Anaplastic Thyroid Carcinoma Via Induction of Autophagy-Dependent Pyroptosis
Background: Anaplastic thyroid carcinoma (ATC) is a lethal malignancy with a dismal prognosis and limited therapeutic options. Although immunotherapy has revolutionized the oncological landscape, the efficacy of Programmed Cell Death Pro...
10
DOI 10.1177/10507256261495636
Open DOI
Smartphone-Based Deep Learning Exophthalmometry in Thyroid Eye Disease: A Multicenter, Multiethnic Validation Study
Background: Proptosis is the principal quantitative measure of disease severity in thyroid eye disease (TED), but Hertel exophthalmometry has substantial interobserver variability and requires in-person specialist visits. Existing deep l...
Bibliographical & Catalog Notes
Quarterly.
Description based on: Vol. 1, no. 2, published 1991; title from cover.
Also issued online.
Complemented by (work): VideoEndocrinology 2329-9738 (DLC) 2013201371 (OCoLC)852502871.
19950523 Not printed on acid-free paper